CATECHOLAMINERGIC MEDIATION OF MORPHINE-INDUCED ACTIVATION OF PITUITARY-ADRENOCORTICAL AXIS IN THE RAT - IMPLICATION OF ALPHA-ADRENOCEPTORS AND BETA-ADRENOCEPTORS

被引:36
作者
MARTINEZPINERO, MG [1 ]
MILANES, MV [1 ]
ALCARAZ, C [1 ]
VARGAS, ML [1 ]
机构
[1] UNIV MURCIA,SCH MED,DEPT PHYSIOL & PHARMACOL,PHARMACOL UNIT,E-30100 MURCIA,SPAIN
关键词
HPA AXIS; MORPHINE; HYPOTHALAMUS; CATECHOLAMINE; RESERPINE; ADRENERGIC BLOCKING DRUG;
D O I
10.1016/0006-8993(94)90518-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present study investigates the role of hypo thalamic catecholamines in the effects of morphine on hypothalamo-pituitary-adrenocortical (HPA) axis. Acutely administered morphine (30 mg/kg i.p) increased plasma corticosterone and reduced the hypothalamic noradrenaline (NA) content but it did not change either the dopamine (DA) concentration or the ratio DOPAC/DA. After reserpine administration the hypothalamic contents of NA and DA were drastically reduced without changing plasma corticosterone concentrations. The increase in plasma corticosterone induced by morphine was significantly reduced by the pretreatment with reserpine. The alpha(1)- and alpha(2)-antagonists prazosin and yohimbine, respectively, significantly antagonized the effect of morphine on plasma corticosterone. The beta-antagonist propranolol also significantly attenuated the increase of corticosterone secretion induced by morphine. The results suggest that the action of the opiate on HPA axis activity may be dependent on stimulatory catecholaminergic systems which utilize alpha(1)-, alpha(2)- and beta-adrenoceptors.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 47 条
[1]   BRATTLEBORO RATS HAVE DEFICIENT ADRENOCORTICOTROPIN RESPONSES TO ACTIVATION OF CENTRAL ALPHA-1-ADRENOCEPTORS [J].
ALDAMLUJI, S ;
WHITE, A ;
BESSER, M .
ENDOCRINOLOGY, 1990, 127 (06) :2849-2853
[2]  
BOROWSKY B, 1991, J PHARMACOL EXP THER, V256, P204
[3]   INTERRELATIONSHIPS OF OPIOIDERGIC AND ADRENERGIC-MECHANISMS CONTROLLING THE SECRETION OF CORTICOTROPIN RELEASING-FACTOR IN THE RAT [J].
BUCKINGHAM, JC ;
COOPER, TA .
NEUROENDOCRINOLOGY, 1987, 46 (03) :199-206
[4]   DIFFERENCES IN HYPOTHALAMO-PITUITARY-ADRENOCORTICAL ACTIVITY IN THE RAT AFTER ACUTE AND PROLONGED TREATMENT WITH MORPHINE [J].
BUCKINGHAM, JC ;
COOPER, TA .
NEUROENDOCRINOLOGY, 1984, 38 (05) :411-417
[6]   PRODUCTION OF CORTICOTROPIN RELEASING HORMONE BY ISOLATED HYPOTHALAMUS OF RAT [J].
BUCKINGHAM, JC ;
HODGES, JR .
JOURNAL OF PHYSIOLOGY-LONDON, 1977, 272 (02) :469-479
[7]   PHARMACOLOGICAL CHARACTERIZATION OF OPIOID RECEPTORS INFLUENCING THE SECRETION OF CORTICOTROPIN RELEASING-FACTOR IN THE RAT [J].
BUCKINGHAM, JC ;
COOPER, TA .
NEUROENDOCRINOLOGY, 1986, 44 (01) :36-40
[8]   THE PHARMACOLOGY OF PRAZOSIN, A NOVEL ANTIHYPERTENSIVE AGENT [J].
CAVERO, I ;
ROACH, AG .
LIFE SCIENCES, 1980, 27 (17) :1525-1540
[9]  
CHERUBINI E, 1985, P NATL ACAD SCI USA, V86, P1860
[10]   RELATIONSHIP OF ALPHA-1-ADRENERGIC-BINDING AND ALPHA-2-ADRENERGIC-BINDING SITES TO REGIONS OF THE PARAVENTRICULAR NUCLEUS OF THE HYPOTHALAMUS CONTAINING CORTICOTROPIN-RELEASING FACTOR AND VASOPRESSIN NEURONS [J].
CUMMINGS, S ;
SEYBOLD, V .
NEUROENDOCRINOLOGY, 1988, 47 (06) :523-532